Advanced Breast Cancer Study of CDK4/6 Inhibitor Combined With Endocrine Therapy Endocrine Therapy in HR+/HER2- Advanced Breast Cancer
Status: NOT_YET_RECRUITING
Study type: INTERVENTIONAL
Conditions: Advanced HR+ HER2 Negative Breast Carcinoma
Interventions: DRUG: (CDK)4/6 inhibitor
Sponsor: Tianjin Medical University Cancer Institute and Hospital